Last reviewed · How we verify
NCT03524131
Randomized Controlled Trial on Uptake of NHS Health Checks
NA trial testing risk-framed leaflet in Cardiovascular Diseases in 12,000 participants. Completed in 30 November 2018.
30 November 2018
Quick facts
| Lead sponsor | Public Health England |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 12,000 |
| Start date | 29 March 2018 |
| Primary completion | 30 November 2018 |
| Estimated completion | 30 November 2018 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- risk-framed leaflet
- benefits-framed leaflet
- current national leaflet
Conditions studied
- Cardiovascular Diseases — all drugs for Cardiovascular Diseases →
Sponsor
Public Health England — full company profile →
Who can join
Adults 40 to 74, any sex, with Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The National Health Service (NHS) Health Check is a significant part of the strategy to tackle premature mortality and promote healthy lifestyles. Public Health England aspires to an uptake rate of 75% but national uptake is less than 50%. This study aims to assess the impact of two new behaviourally informed NHS Health Check leaflets on the uptake of NHS Health Checks, by randomizing patients in Lewisham and North East Lincolnshire to the different leaflets and comparing patient-level uptake data. The study will test whether a shorter risk-framed leaflet or a shorter benefits-framed leaflet will be more effective than the current national leaflet at encouraging uptake of the NHS Health Check.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Applying behavioural science to increase uptake of the NHS Health Check: a randomised controlled trial of gain- and loss-framed messaging in the national patient information leaflet.
Gold N, Durlik C, Sanders JG, Thompson K, et al · · 2019 · cited 11× · PMID 31727030 · DOI 10.1186/s12889-019-7754-5
Verify or expand the search:
- PubMed search for NCT03524131
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cardiovascular Diseases
Currently open trials in the same condition.
- NCT07442578 — Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial · NA · active not recruiting
- NCT07426263 — Effectiveness of a Therapeutic Education Program on Female Sexuality in Women Attending Cardiac Rehabilitation. · NA · active not recruiting
- NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
- NCT07324278 — Hybrid Stroke Rehab With Mirror Priming · NA · recruiting
- NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting
Other Public Health England trials
Trials by the same sponsor.
- NCT04051281 — CMO Letter to Reduce Inappropriate Antibiotic Prescribing Winter 2019/2020 · NA · completed
- NCT03862794 — CMO Letter to Reduce Unnecessary Antibiotic Prescribing and Broad Spectrum Prescribing Winter 2018-9 · NA · completed
- NCT03745131 — Cohort Study of Healthcare Workers Receiving Imvanex® · completed
- NCT03582072 — CMO Letter to Reduce Unnecessary Antibiotic Prescribing March 2018 · NA · completed
- NCT03407690 — A Study to Assess the Carriage of Pneumococci in Children Aged ≤8 Years, and Their Household Contacts · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03524131 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Public Health England
- Last refreshed: 3 March 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03524131.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing